Liposomal amphotericin B, voriconazole, and caspofungin are currently used for systemic and severe fungal infections. Patients with malignant diseases are treated with granulocyte-colony stimulating factor (G-CSF) for the recovery of granulocytes after chemotherapy or hematopoietic cell (HC) transplantation. Since they have a high incidence of fungal infections, they inevitably receive antifungal drugs for treatment and prophylaxis. Despite their proven less toxicity for various cell types comparatively with amphotericin B and the decrease in the number of leukocytes that has been reported as a possible complication in clinical studies, the effect of liposomal amphotericin B, voriconazole, and caspofungin on HCs has not been clarified. The ...
Systemic fungal infections are an important cause of morbidity and mortality among immunocompromised...
Cryptococcosis is a subacute or chronic systemic mycosis with a cosmopolitan nature, caused by yeast...
An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in ...
Groll AH, Silling G, Young C, et al. Randomized Comparison of Safety and Pharmacokinetics of Caspofu...
Invasive Fungal Infections (IFI) remain a severe and major complication among patients with hematolo...
Data on the use of combination of liposomal amphotericin B and caspofungin followed by voriconazole,...
Data on the use of combination of liposomal amphotericin B and caspofungin followed by voriconazole,...
his multicentre observational study evaluated the feasibility, efficacy and toxicity of antifungal c...
This multicentre observational study evaluated the feasibility, efficacy and toxicity of antifungal ...
textabstractAdvances in medical treatment have improved the prognosis for patients with cancer. Whil...
ABSTRACTCaspofungin, in association with other antifungal drugs, was administered as rescue therapy ...
This multicentre observational study evaluated the feasibility, efficacy and toxicity of antifungal ...
Contains fulltext : 142705.pdf (publisher's version ) (Closed access)The aim of th...
Introduction: The Combination (Combo) antifungal therapy is a very hot topic in haematology. This m...
This multicentre observational study evaluated the feasibility, efficacy and toxicity of antifungal ...
Systemic fungal infections are an important cause of morbidity and mortality among immunocompromised...
Cryptococcosis is a subacute or chronic systemic mycosis with a cosmopolitan nature, caused by yeast...
An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in ...
Groll AH, Silling G, Young C, et al. Randomized Comparison of Safety and Pharmacokinetics of Caspofu...
Invasive Fungal Infections (IFI) remain a severe and major complication among patients with hematolo...
Data on the use of combination of liposomal amphotericin B and caspofungin followed by voriconazole,...
Data on the use of combination of liposomal amphotericin B and caspofungin followed by voriconazole,...
his multicentre observational study evaluated the feasibility, efficacy and toxicity of antifungal c...
This multicentre observational study evaluated the feasibility, efficacy and toxicity of antifungal ...
textabstractAdvances in medical treatment have improved the prognosis for patients with cancer. Whil...
ABSTRACTCaspofungin, in association with other antifungal drugs, was administered as rescue therapy ...
This multicentre observational study evaluated the feasibility, efficacy and toxicity of antifungal ...
Contains fulltext : 142705.pdf (publisher's version ) (Closed access)The aim of th...
Introduction: The Combination (Combo) antifungal therapy is a very hot topic in haematology. This m...
This multicentre observational study evaluated the feasibility, efficacy and toxicity of antifungal ...
Systemic fungal infections are an important cause of morbidity and mortality among immunocompromised...
Cryptococcosis is a subacute or chronic systemic mycosis with a cosmopolitan nature, caused by yeast...
An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in ...